Compare Novavax Inc (NVAX) vs Trade Desk Inc (TTD) Price & Performance

Novavax IncTrade

Trade Desk IncTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Trade Desk Inc — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while Trade Desk Inc trades at $13.5 (market cap $6.37B). The key difference: Trade Desk Inc is far larger — about 4.9× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals.

	NVAX	TTD
Market Cap	$1.31B	$6.37B
Sector	Health	Technology
52-Week High	$11.19	$55.36
52-Week Low	$6.22	$13.39
Enterprise Value	$889.30M	$5.32B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVAX

View details →

TTD

Court allows thousands of social media addiction lawsuits against Meta and others to proceedForbes · 1 day agoBearish Trade Desk shares drop 5% after Q2 earnings miss and weak guidance, signaling execution issues.24/7 Wall Street · 1 day agoBearish HSBC downgrades The Trade Desk after weak Q2 results and poor Q3 outlook, stock drops 28%.Andrew Wynn · 2 days agoBearish View details →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

About Trade Desk Inc

The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.